Dyne Therapeutics DYN
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$0.00
Operating profit-$197.07M-73.0% YoY
Net profit-$193.55M-79.1% YoY
Diluted EPS-$1.06-39.5% YoY
Free cash flow-$179.50M-63.2% YoY
Operating cash flow-$177.49M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-74.6%
Return on assets-57.6%
Return on invested capital-63.3%
Current ratio12.99
Liabilities / assets24.6%
Cash & investments$1.13B
Total debt$213.32M
Net cash (debt)$921.06M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $197.07M | $181.66M | $125.28M | $468.18M | $116.13M |
| Selling and Admin Expenses | $35.33M | $29.49M | $24.39M | $69.85M | $20.70M |
| -General & Admin Expense | $35.33M | $29.49M | $24.39M | $69.85M | $20.70M |
| Research & Development | $161.74M | $152.17M | $100.89M | $398.33M | $95.43M |
| Operating Profit | -$197.07M | -$181.66M | -$125.28M | -$468.18M | -$116.13M |
| Net Non-Operating Interest Income (Expense) | $3.82M | $3.19M | $4.56M | $23.67M | $4.46M |
| Non-Operating Interest Income | $9.77M | $7.79M | $8.76M | $29.86M | $7.66M |
| Non-Operating Interest Expense | $5.95M | $4.60M | $4.20M | $6.19M | $3.19M |
| Other Income (Expense) | -$296,000.00 | -$88,000.00 | -$133,000.00 | -$1.70M | -$289,000.00 |
| Other Non-Operating Income (Expenses) | -$296,000.00 | -$88,000.00 | -$133,000.00 | -$1.70M | -$289,000.00 |
| Pretax Profit | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Net Profit | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Profit from Continuing Operations | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Net Income to Parent Company | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Net Income to Common Stockholders | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Basic EPS | -$1.06 | -$1.08 | -$0.73 | -$3.47 | -$0.76 |
| Diluted EPS | -$1.06 | -$1.08 | -$0.73 | -$3.47 | -$0.76 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.23B | $994.01M | $1.08B | $1.19B | $1.19B |
| Total Current Assets | $1.18B | $937.89M | $1.02B | $1.13B | $1.13B |
| Cash and Cash Equivalents & Short-Term Investments | $1.13B | $898.48M | $972.16M | $1.11B | $1.11B |
| -Cash and Cash Equivalents | $913.20M | $676.11M | $753.10M | $893.37M | $893.37M |
| -Short Term Investments | $221.18M | $222.36M | $219.05M | $217.19M | $217.19M |
| Other Current Assets | $41.64M | $39.41M | $48.87M | $16.03M | $16.03M |
| Total Non-Current Assets | $58.77M | $56.12M | $58.92M | $60.37M | $60.37M |
| Net PPE | $26.17M | $44.82M | $43.33M | $44.77M | $44.77M |
| -Gross PPE | $36.54M | $54.54M | $52.50M | $53.49M | $53.49M |
| -Accumulated Depreciation | -$10.37M | -$9.73M | -$9.17M | -$8.72M | -$8.72M |
| Other Non-Current Assets | $32.60M | $11.31M | $15.59M | $15.60M | $15.60M |
| Total Liabilities | $303.87M | $291.86M | $214.90M | $214.83M | $214.83M |
| Total Current Liabilities | $90.55M | $78.03M | $51.25M | $50.63M | $50.63M |
| Payables | $14.90M | $12.15M | $10.78M | $8.08M | $8.08M |
| -Accounts Payable | $14.90M | $12.15M | $10.78M | $8.08M | $8.08M |
| Current Accrued Expenses | $44.12M | $46.36M | $29.21M | $37.55M | $37.55M |
| Short-Term Debt and Capital Lease Obligation | $5.56M | $5.37M | $5.03M | $5.00M | $5.00M |
| -Current Capital Lease Obligation | $5.56M | $5.37M | $5.03M | $5.00M | $5.00M |
| Other Current Liabilities | $25.97M | $14.15M | $6.22M | – | – |
| Total Non-Current Liabilities | $213.32M | $213.83M | $163.65M | $164.20M | $164.20M |
| Long Term Debt and Capital Lease Obligation | $213.32M | $213.83M | $163.65M | $164.20M | $164.20M |
| -Long Term Debt | $200.01M | $199.33M | $149.38M | $148.92M | $148.92M |
| -Long Term Capital Lease Obligation | $13.31M | $14.51M | $14.27M | $15.28M | $15.28M |
| Total Equity | $930.93M | $702.15M | $865.06M | $972.13M | $972.13M |
| Stockholders' Equity | $930.93M | $702.15M | $865.06M | $972.13M | $972.13M |
| Capital Stock | $18,000.00 | $16,000.00 | $16,000.00 | $16,000.00 | $16,000.00 |
| -Common Stock | $18,000.00 | $16,000.00 | $16,000.00 | $16,000.00 | $16,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $2.82B | $2.40B | $2.38B | $2.37B | $2.37B |
| Retained Earnings | -$1.89B | -$1.70B | -$1.52B | -$1.40B | -$1.40B |
| Gains/Losses Not Affecting Retained Earnings | -$1.00M | -$353,000.00 | -$137,000.00 | $475,000.00 | $475,000.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$177.49M | -$130.29M | -$144.92M | -$403.21M | -$111.83M |
| Net cash flow from continuing operations | -$177.49M | -$130.29M | -$144.92M | -$403.21M | -$111.83M |
| Net Income from Continuing Operations | -$193.55M | -$178.56M | -$120.85M | -$446.21M | -$111.96M |
| Gain/Loss from Continuing Operations | $36,000.00 | – | – | $65,000.00 | -$16,000.00 |
| Depreciation & Depletion & Amortization | $641,000.00 | $560,000.00 | $550,000.00 | $2.05M | $521,000.00 |
| Other Non-Cash Items | $344,000.00 | $178,000.00 | $195,000.00 | $281,000.00 | $91,000.00 |
| Change in Working Capital | -$936,000.00 | $32.80M | -$37.62M | -$3.40M | -$11.31M |
| -Change in Prepaid Assets | -$2.38M | $9.48M | -$32.85M | $986,000.00 | -$2.20M |
| -Change in Payables and Accrued Expense | $1.72M | $18.96M | -$4.80M | $8.25M | -$9.46M |
| -Change in Other Current Assets | -$272,000.00 | $4.35M | $28,000.00 | -$12.64M | $350,000.00 |
| Net cash flow from investing | -$1.29M | -$4.80M | -$2.39M | -$28.75M | $982,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$1.29M | -$4.80M | -$2.39M | -$28.75M | $982,000.00 |
| Net PPE Purchase and Sale | -$2.01M | -$1.51M | -$221,000.00 | -$20.71M | -$484,000.00 |
| Net Investment Purchase and Sale | $719,000.00 | -$3.28M | -$2.17M | -$8.04M | $1.47M |
| Financing Cash Flow | $418.10M | $58.11M | $7.06M | $890.31M | $430.97M |
| Net Cash Flow from Continuing Financing Activities | $418.10M | $58.11M | $7.06M | $890.31M | $430.97M |
| Net Issuance Payments Of Debt | $11.23M | $57.37M | $6.21M | $148.26M | $49.45M |
| Net Common Stock Issuance | $404.91M | $0.00 | $0.00 | $734.61M | $378.15M |
| Proceeds from Stock Option Exercised | $2.03M | $737,000.00 | $1.31M | $8.00M | $3.37M |
| Net Other Financing Charges | -$56,000.00 | $0.00 | -$454,000.00 | -$558,000.00 | -$9,000.00 |
| Ending Cash Balance | $917.84M | – | – | $895.74M | $895.74M |
| Net Change in Cash | $239.32M | – | – | $458.35M | $320.12M |
| Beginning Cash Balance | $678.52M | – | – | $437.39M | $575.63M |
| Free Cash Flow | -$179.50M | -$131.80M | -$145.14M | -$423.92M | -$112.32M |
No comments yet — be the first to weigh in on DYN.
Sign in to join the discussion.